Kochmanski Joseph, Virani Mahek, Kuhn Nathan C, Boyd Sierra L, Becker Katelyn, Adams Marie, Bernstein Alison I
Department of Translational Neuroscience, College of Human Medicine, Michigan State University, Grand Rapids, MI 49503, United States.
Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, United States.
Toxicol Sci. 2024 Oct 1;201(2):263-281. doi: 10.1093/toxsci/kfae091.
Epidemiological studies show that exposure to the organochlorine pesticide dieldrin is associated with an increased risk of Parkinson's disease (PD). Animal studies support a link between developmental dieldrin exposure and increased neuronal susceptibility in the α-synuclein preformed fibril and MPTP models in adult male C57BL/6 mice. In a previous study, we showed that developmental dieldrin exposure was associated with sex-specific changes in DNA modifications within genes related to dopaminergic neuron development and maintenance at 12 wk of age. Here, we used capture hybridization-sequencing with custom baits to interrogate DNA modifications across the entire genetic loci of the previously identified genes at multiple time points-birth, 6, 12, and 36 wk old. We identified largely sex-specific dieldrin-induced changes in DNA modifications at each time point that annotated to pathways important for neurodevelopment, potentially related to critical steps in early neurodevelopment, dopaminergic neuron differentiation, synaptogenesis, synaptic plasticity, and glial-neuron interactions. Despite large numbers of age-specific DNA modifications, longitudinal analysis identified a small number of differential modification of cytosines with dieldrin-induced deflection of epigenetic aging. The sex-specificity of these results adds to evidence that sex-specific responses to PD-related exposures may underly sex-specific differences in disease. Overall, these data support the idea that developmental dieldrin exposure leads to changes in epigenetic patterns that persist after the exposure period and disrupt critical neurodevelopmental pathways, thereby impacting risk of late-life diseases, including PD.
流行病学研究表明,接触有机氯农药狄氏剂与帕金森病(PD)风险增加有关。动物研究支持发育过程中接触狄氏剂与成年雄性C57BL/6小鼠α-突触核蛋白预制纤维和MPTP模型中神经元易感性增加之间存在联系。在先前的一项研究中,我们表明,发育过程中接触狄氏剂与12周龄时多巴胺能神经元发育和维持相关基因的DNA修饰中的性别特异性变化有关。在这里,我们使用定制诱饵的捕获杂交测序技术,在多个时间点——出生、6周、12周和36周龄,对先前鉴定基因的整个基因座的DNA修饰进行检测。我们在每个时间点都发现了狄氏剂诱导的DNA修饰变化,这些变化在很大程度上具有性别特异性,且与对神经发育重要的通路相关,可能与早期神经发育、多巴胺能神经元分化、突触形成、突触可塑性和神经胶质-神经元相互作用的关键步骤有关。尽管有大量年龄特异性的DNA修饰,但纵向分析发现,少数胞嘧啶的差异修饰伴随着狄氏剂诱导的表观遗传衰老偏差。这些结果的性别特异性进一步证明,对PD相关暴露的性别特异性反应可能是疾病中性别特异性差异的基础。总体而言,这些数据支持这样一种观点,即发育过程中接触狄氏剂会导致表观遗传模式的变化,这些变化在接触期后持续存在,并扰乱关键的神经发育通路,从而影响包括PD在内的晚年疾病风险。